EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 37 / No 3 (September 2005) J Extra Corpor Technol, 37 3 (2005) 296-302 References
Free Access
Issue
J Extra Corpor Technol
Volume 37, Number 3, September 2005
Page(s) 296 - 302
DOI https://doi.org/10.1051/ject/200537296
Published online 15 September 2005
  1. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995;332:1330–5. [CrossRef] [PubMed] [Google Scholar]
  2. Trossaert M, Gaillard A, Commin PL, Amiral J, Vissac AM, Fressinaud E. High incidence of anti-heparin/platelet factor 4 antibodies after cardiolpulmonary bypass surgery. Br J Haematol. 1998;101: 653–5. [CrossRef] [PubMed] [Google Scholar]
  3. Pouplard C, May MA, Iochmann S, et al. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low molecular-weight heparin: Clinical implications for heparin-induced thrombocytopenia. Circulation. 1999;99:2530–6. [CrossRef] [PubMed] [Google Scholar]
  4. Mattioli AV, Bonetti L, Sternieri S, Mattioli G. Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: Prevalence of thrombosis in a 1 year follow-up. Italian Heart J. 2000;1:39–42. [Google Scholar]
  5. Mascelli MA, Deliargyris EN, Damaraju LV, Barnathan ES, Sane DC. Role of anti-PF4/heparin antibodies in recurrent thrombotic events after acute coronary syndromes. Semin Thromb Hemost. 2004;30:347–50. [CrossRef] [PubMed] [Google Scholar]
  6. Slaughter TF, Bennett-Guerrero E, Su Z, et al. Antiheparin/PF4 antibodies detected prior to cardiac surgery identify patients at high risk for adverse perioperative outcomes. Anesth Analg. 2002;93:SCA28. [Google Scholar]
  7. Longrois D, de Maistre E, Bischoff N, et al. Recombinant hirudin anticoagulation for aortic valve replacement in heparin-induced thrombocytopenia. Can J Anaesth. 2000;47:255–60. [CrossRef] [PubMed] [Google Scholar]
  8. Vasquez JC, Vichiendilokkul A, Mahmood S, et al. Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery. Ann Thorac Surg. 2002;74:2177–9. [CrossRef] [Google Scholar]
  9. Davis Z, Anderson R, Short D, et al. Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass. Ann Thorac Surg. 2003;75:264–5. [CrossRef] [Google Scholar]
  10. Gordon G, Rastegar H, Schumann R, Deiss-Shrem J, Denman W. Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia. J Cardiothorac Vasc Anesth. 2003;17:632–5. [CrossRef] [Google Scholar]
  11. Clayton SB, Acsell Jr, Crumbley AJ, Uber WE. Cardiopulmonary bypass with bivalirudin in type II heparin-induced thrombocytopenia. Ann Thorac Surg. 2004;78:2167–9. [CrossRef] [Google Scholar]
  12. Dyke CM, Koster A, Veale JJ, Maier GW, McNiff T, Levy MD. Preemptive use of bivalirudin for urgent on-pump coronary artery bypass grafting in patients with potential heparin-induced thrombocytopenia. Ann Thorac Surg. 2005;80:299–303. [CrossRef] [Google Scholar]
  13. Koster A, Spiess B, Chew D. Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. Am J Cardiol. 2004;93:356–9. [CrossRef] [Google Scholar]
  14. Bittl JA, Chaitman B, Feit F, et al. Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study. Am Heart J. 2001;142:952–9. [CrossRef] [Google Scholar]
  15. Angiomax Package Insert The Medicines Company, Parsippany, NJ. [Google Scholar]
  16. Merry AF, Raudkivi PJ, Middleton NJ, McDougall JM, Nand P, Mills BP, et al. Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery. Ann Thorac Surg. 2004;77:925–31. [CrossRef] [Google Scholar]
  17. Palmer George. Personal Communication. [Google Scholar]
  18. The Medicines Company. Protocol No. TMC-BIV-02-06. A Study Comparing Angiomax® (Bivalirudin) to Heparin with Protamine Reversal in Patients Undergoing Cardiac Surgery. [Google Scholar]
  19. Koster A, Yeter A, Buz S, et al. Hemostatic activation during normothermic cardiopulmonary bypass with bivalirudin: Results of the second pilot study to assess “on-pump” coronary artery bypass grafting with bivalirudin. J Thorac Cardiovasc Surg. 2005;129:1391–4. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.